Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 1, 1998, Pages 40-44

  Otsubo, Takakazu ^a   Maruyama, Kazuo ^b   Maesaki, Shigefumi ^a   Miyazaki, Yoshitsugu ^a   Tanaka, Eitaro ^b   Takizawa, Tomoko ^b   Moribe, Kunikazu ^b   Tomono, Kazunori ^a   Tashiro, Takayoshi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; DRUG CARRIER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; DRUG BINDING; DRUG BLOOD LEVEL; DRUG EFFICACY; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 0031973604     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.1.40     Document Type: Article

References (21)

1. Bruggemann, M., G. Winter, H. Waldmann, and M. S. Neuberger. 1989. The immunogenicity of chimeric antibodies. J. Exp. Med. 170:2153-2157.
2. Defaveri, J., M. H. Salazar, M. G. Rinaldi, and J. R. Graybill. 1990. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304. Am. Rev. Respir. Dis. 142:512-515.
3. Denning, D. W. 1994. Treatment of invasive aspergillosis. J. Infect. 28(Suppl. 1):25-33.
4. Graybill, J. R., P. C. Craven, R. L. Taylor, D. M. Williams, and W. E. Maree. 1982. Treatment of murine cryptococcosis with liposomal-associatcd amphotericin B. J. Infect. Dis. 145:748-752.
5. Hay, R. J. 1994. Liposomal amphotericin B, AmBisome. J. Infect. 28(Suppl. I):35-43.
6. Hughes, B. J., S. Kennel, R. Lee, and L. Huang. 1989. Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res. 49:6214-6220.
7. Jullien, S., J. Brajburg, and J. Bolard. 1990. Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations. Biochim. Biophys. Acta 1021:39-45.
8. Kennel, S. J., T. Lankford, B. Hughes, and J. A. Hotchkiss. 1988. Quantitation of a murine lung endothelial cell protein. P112, with a double monoclonal antibody assay. J. Lab. Invest. 59:692-701.
9. Kennel, S. J., R. Falcioni, and J. W. Wesley. 1991. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Cancer Res. 51:1529-1536.
10. Klibanov, A. L., K. Maruyama, A. M. Beckerleg, V. P. Torchilin, and L. Huang. 1991. Activity of amphipathic poly(ethylene glycol)5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1062: 142-148.
11. Krause, H. J., and R. L. Juliano. 1988. Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures. Mol. Pharmacol. 34:286-297.
12. Lopez-Berestein, G., R. Mehta, R. L. Hopfer, K. Mills, L. Kasi, K. Mehta, V. Fainstein, M. Luna, E. M. Hersh, and R. L. Juliano. 1983. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J. Infect. Dis. 147:939-945.
13. Maruyama, K., E. Holmberg, S. J. Kennel, A. Klibanov, V. P. Torchilin, and L. Huang. 1990. Characterization of in vivo immunoliposome targeting to pulmonary endothelium. J. Pharm. Sci. 79:978-984.
14. Maruyama, K., A. Okamoto, O. Ishida, S. Kojima, A. Suginaka, L. Huang, and M. Iwatsuru. 1994. Biodistribution and antitumor effect of adriamycin encapsulated in long-circulating liposomes containing amphipathic polyethylene glycol or ganglioside GM1. J. Liposome Res. 4:701-723.
15. Maruyama, K., T. Takizawa, T. Yuda, S. J. Kennel, L. Huang, and M. Iwatsuru. 1995. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminal to monoclonal antibodies. Biochim. Biophys. Acta 1234:74-80.
16. Ringden, O., F. Meunier, J. Tollemar, P. Ricci, S. Tura, E. Kuse, M. A. Viviani, N. C. Gorin, J. Klastersky, P. Fenaux, H. G. Prentice, and G. Ksionski. 1991. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J. Antimicrob. Chemother. 28(Suppl. B):73-82.
17. Rorvik, M. C., D. P. Allison, J. A. Hotchkiss, H. P. Witschi, and S. J. Kennel. 1988. Antibodies to mouse lung capillary endothelium. J. Histochem. Cytochem. 36:741-749.
18. Uyama, I., K. Kumai, T. Yasuda, T. Tagawa, K. Ishibiki, M. Kitajima, and T. Tadakuma. 1994. Improvement of therapeutic effect by using Fab' fragment in the treatment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoliposomes. Jpn. J. Cancer Res. 85:434-440.
19. van Etten, E. W. M., M. Otte-Lambillion, W. van Vianen, M. T. ten Kate, and I. A. M. Bakker-Woudenberg. 1995. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans. J. Antimicrob. Chemother. 35:509-519.
20. van Etten, E. W. M., M. T. ten Kate, L. E. T. Stearne, and I. A. M. Bakker-Woudenberg. 1995. Amphotericin B liposomes prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice. Antimicrob. Agents Chemother. 39:1954-1958.
21. Wassan, K. M., K. Vadiel, G. Lopez-Berestein, and D. R. Luke. 1990. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. J. Infect. Dis. 161:562-566.